Topics

Amgen says Kyprolis, Darzalex combination hits main goal in Phase III multiple myeloma trial https://www.firstwordpharma.com/node/1666128?tsid=33 …

11:45 EDT 13 Sep 2019 | FirstWord Pharma

Amgen says Kyprolis, Darzalex combination hits main goal in Phase III multiple myeloma trial https://www.firstwordpharma.com/node/1666128?tsid=33 …

Original Article: Amgen says Kyprolis, Darzalex combination hits main goal in Phase III multiple myeloma trial https://www.firstwordpharma.com/node/1666128?tsid=33 …

NEXT ARTICLE

More From BioPortfolio on "Amgen says Kyprolis, Darzalex combination hits main goal in Phase III multiple myeloma trial https://www.firstwordpharma.com/node/1666128?tsid=33 …"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...